Company / R&D Expense
ALUMIS INC. R&D Expense History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$386.0M
FY2025
5-year range
$137.7M / $386.0M
FY2023-FY2025
Trend
+45.4%
vs FY2024
Sector context
#45 of 210
Health Care
What the data says
ALUMIS INC.'s r&d expense of $386M is higher than 79% of companies in the Health Care sector (FY2025). Improved from $138M to $386M over the past 2 years.
Based on SEC 10-K filings.
$386M in FY2025. Top quartile in the Health Care sector.
Improved from $138M to $386M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 210This company $386.0M Sector average $644.0M
▼
-40.1% below sector average
Key checks
Key Insights
- In FY2025, r&d expense increased 45.4% year-over-year.
- Ranks #45 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.65 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $386.0M | +45.4% |
| FY2024 | $265.6M | +92.9% |
| FY2023 | $137.7M | - |
As of FY2025 · SEC 10-K · Updated Mar 21, 2026